Status:

Red

Decision Date:

None

Comments

RED⁸: NICE TA643 - for treating ROS1-positive advanced non-small cell lung cancer (Decision date - September 2020) 

RED⁸: NICE TA644 - for treating NTRK fusion-positive solid tumours. (Decision date - September 2020) 

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again